Your session is about to expire
← Back to Search
Biomechanical Modeling for Abdominal Aortic Aneurysm (AAA2D3DIII Trial)
N/A
Recruiting
Led By Gilles Soulez, MD,MSc
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with a clinical indication for EVAR/FEVAR of AAA and meeting anatomic inclusion criteria on preoperative enhanced CT-scan compatible with an endovascular repair
Willing and capable of providing informed consent
Must not have
Contraindication to endovascular repair
Creatinine clearance < 30ml/min
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at using a computer program to help guide surgeons during a procedure to fix an abdominal aortic aneurysm.
Who is the study for?
This trial is for individuals who need a procedure called EVAR/FEVAR to repair an abdominal aortic aneurysm and can give informed consent. They must have suitable anatomy as seen on a recent enhanced CT scan and good kidney function (creatinine clearance above 30ml/min). People with severe allergies to iodinated contrast or those without the required type of CT scan are not eligible.
What is being tested?
The study tests a biomechanical computer program designed to simulate and improve the endovascular repair process for abdominal aortic aneurysms in real-time, using patient-specific data from clinical interventions and preoperative imaging.
What are the potential side effects?
Since this trial involves testing software rather than drugs or medical procedures, traditional side effects are not applicable. However, there may be risks associated with inaccuracies in simulation leading to less optimal surgical outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a candidate for a specific type of surgery to repair an abdominal aortic aneurysm based on my CT scan results.
Select...
I am willing and able to give my consent for treatment.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot undergo procedures involving catheters in my blood vessels.
Select...
My kidney function is reduced with a creatinine clearance below 30ml/min.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 0
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinical validation of the biomechanical prototype software
Secondary study objectives
Contrast agent used
Fluoroscopy time
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Rigid and Elastic registration softwaresExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Siemens Corporation, Corporate TechnologyIndustry Sponsor
22 Previous Clinical Trials
9,412 Total Patients Enrolled
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
377 Previous Clinical Trials
131,500 Total Patients Enrolled
3 Trials studying Aortic Aneurysm
100 Patients Enrolled for Aortic Aneurysm
MedTeqIndustry Sponsor
7 Previous Clinical Trials
498 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a candidate for a specific type of surgery to repair an abdominal aortic aneurysm based on my CT scan results.I am willing and able to give my consent for treatment.I cannot undergo procedures involving catheters in my blood vessels.My kidney function is reduced with a creatinine clearance below 30ml/min.You have had a serious allergic reaction to iodinated contrast.You have not had a recent detailed CT scan using contrast dye, or a stent planned based on an MRI or non-detailed CT scan.
Research Study Groups:
This trial has the following groups:- Group 1: Rigid and Elastic registration softwares
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger